⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL256335 | 0.75 | — | — | |
| SCHEMBL665505 | 0.67 | — | — | |
| SCHEMBL10296571 | 0.61 | — | — | |
| SCHEMBL9926415 | 0.60 | — | — | |
| SCHEMBL10296525 | 0.60 | — | — | |
| SCHEMBL10296577 | 0.58 | — | — | |
| SCHEMBL824748 | 0.55 | — | — | |
| SCHEMBL17581083 | 0.51 | — | — | |
| SCHEMBL7703054 | 0.48 | — | — | |
| SCHEMBL121778 | 0.48 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3566719-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES | Cerulean Pharma Inc. (US) | 2019-11-13 | — | — | EP | disclosed |
| WO-2019160813-A1 | ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF | ENANTA PHARMACEUTICALS, INC. (US) | 2019-08-22 | — | — | WO | disclosed |
| WO-2017193041-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES (US) | 2017-11-09 | — | — | WO | disclosed |
| US-9540370-B2 | Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors | ABBVIE DEUTSCHLAND GMBH & CO., KG. (DE) | 2017-01-10 | — | — | US | disclosed |
| US-20150336985-A1 | FUNGICIDAL HETEROCYCLIC COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY | 2015-11-26 | — | — | US | disclosed |
| US-20150336985-A1 | FUNGICIDAL HETEROCYCLIC COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY | 2015-11-26 | — | — | US | disclosed |
| US-20150274724-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-10-01 | — | — | US | disclosed |
| US-9090592-B2 | Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-07-28 | — | — | US | disclosed |
| WO-2015103215-A1 | DIBENZOSUBERANE-BASED ELECTRON-TRANSPORT MATERIALS | UNIVERSITY OF WASHINGTON (US) | 2015-07-09 | — | — | WO | disclosed |
| EP-1552574-B1 | PROTON-CONDUCTING POLYMER MEMBRANE COMPRISING SULFONIC ACID-CONTAINING POLYAZOLES, AND USE THEREOF IN FUEL CELLS | BASF FUEL CELL RES GMBH (DE) | 2013-06-19 | — | — | EP | disclosed |
| EP-2052006-B1 | CONJUGATED POLYMERS, PROCESS FOR THEIR PREPARATION AND THEIR USE | MERCK PATENT GMBH (DE) | 2013-06-12 | — | — | EP | disclosed |
| US-20120172376-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS | ABBOTT GMBH & CO. KG (DE) | 2012-07-05 | — | — | US | disclosed |
| WO-2012020742-A1 | NOVEL HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 塩野義製薬株式会社 (JP) | 2012-02-16 | — | — | WO | disclosed |
| US-20110095283-A1 | FLUORINE-BRIDGED ASSOCIATIONS FOR OPTOELECTRONIC APPLICATIONS | MERCK PATENT GMBH (DE) | 2011-04-28 | — | — | US | disclosed |
| CN-101842375-A | Process for preparing TEDA derivatives | BASF SE | 2010-09-22 | — | — | CN | disclosed |
| EP-1349005-B1 | Photosensitive compound, resin and composition | TOYO GOSEI CO LTD (JP) | 2010-09-01 | — | — | EP | disclosed |
| US-20100204438-A1 | METHOD FOR PRODUCING TEDA DERIVATIVES | BASF SE (DE) | 2010-08-12 | — | — | US | disclosed |
| EP-2197882-A2 | METHOD FOR PRODUCING TEDA DERIVATIVES | Basf Se (DE) | 2010-06-23 | — | — | EP | disclosed |
| WO-2009030649-A2 | METHOD FOR PRODUCING TEDA DERIVATIVES | BASF SE (DE) | 2009-03-12 | — | — | WO | disclosed |
| WO-2003015774-A1 | COMPOUNDS EFFECTING GLUCOKINASE | ASTRAZENECA AB (SE) | 2003-02-27 | — | — | WO | disclosed |